Abata Therapeutics was a biotechnology company developing engineered regulatory T cell (Treg) therapies aimed at restoring immune tolerance in tissue-specific autoimmune and inflammatory diseases, with lead programs directed at progressive multiple sclerosis and type 1 diabetes. - View it on GitHub